Tobacco use widely impacts oral and systemic health, with more diseases and mechanisms reported with each new Surgeon General’s Report. This presentation provides an overview of the impact of tobacco on oral and systemic health, and specifically addresses mechanisms of action by which smoked and smokeless tobacco affect risk and oral disease progression. An overview of the evidence for improvements in oral and systemic health following tobacco cessation is discussed, followed by the available evidence on the role, safety and efficacy of nicotine replacement therapy and other tobacco cessation products will be examined. Results of tobacco cessation programs in the dental office are also discussed.
- List and describe oral and systemic diseases caused by or associated with the use of tobacco
- Review the mechanisms by which tobacco influences risk and progression of periodontal disease, caries and oral cancer
- Describe nicotine-replacement therapies and non-nicotine therapies used for tobacco cessation and their efficacy
Dr. Collins is a member of the American Dental Association, ADA Standards working groups, American Association of Dental Research, Chicago Dental Society, and OSAP. She is the ADA representative to AAMI, and a Fellow of the Pierre Fauchard Academy. During her career, Fiona has lived and worked in five countries, and has held positions in clinical practice, education and industry. Dr. Collins graduated as a general dentist from the University of Glasgow in Scotland, and holds an MBA and an MA from Boston University in the United States.